(Q37269304)
Statements
1 reference
A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. (English)
1 reference
Miroslava Macova
1 reference
Jaroslav Pavel
1 reference
Juan M Saavedra
1 reference
12 November 2008
1 reference
1 reference
1250
1 reference
130-140
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference